Antibody pairs for identifying SARS-CoV-2 N protein
Updated time: 2020-11-17 17:56:44
Antibody pairs for identifying SARS-CoV-2 N protein
Docket Number
28A-1090916
Announcement Date
2020-11-17
IP Status
USP Pending
Abstract
In this invention, we describe molecular engineering methods to enhance FRIL’s antiviral effect and decrease antigenicity, and molecular cloning of FRIL to engineer specific sites for easier enzyme cleavage.
Technological Advantages
- The antibody screening is in-vitro system which can produce multiple antibodies at the same time.
- The screening system is optimized for lateral flow devices.
- Antibodies can be further optimized if necessary.
Applications of Technology
- Lateral flow immunoassay for detecting SARS-CoV-2 N protein
- Combination of rapid test kits for upper respiratory tract infection (corona virus and influenza virus, for example).
Inventor
An-Suei Yang, Chung-Ming Yu, Chao-Ping Tung, Horng-Ru Hsu, Hung-Pin Peng, Chi-Yung Chen, Yu-Chuan Huang, Pei-Hsun Tsai, Szu-Yu Lin, Fei-Hung Hung
Contact person
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office
Download Files

Antibody pairs for identifying SARS-CoV-2 N protein